Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort
Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort
复制标题
DOI：
10.1136/annrheumdis-2020-218705
复制
发表时间：
2021-02-01
影响因子：
27.4
通讯作者：
Finckh, Axel
中科院分区：
文献类型：
--
作者：
Ciurea, Adrian;Papagiannoulis, Eleftherios;Finckh, Axel
目的 调查 COVID-19 大流行期间病毒遏制措施造成的风湿病服务的暂时减少是否与中轴型脊柱关节炎 (axSpA)、类风湿性关节炎 (RA) 或银屑病关节炎 (PsA) 的疾病恶化有关。方法在每 2 个月持续时间的三个时期（治疗前、治疗期间和治疗后）之间比较在面对面就诊和/或通过智能手机应用程序评估的患者报告的疾病活动度。 2020 年 1 月至 6 月，瑞士临床质量管理队列中 666 名 axSpA、RA 和 PsA 患者接受了新冠肺炎 (COVID-19-wave) 治疗。结果会诊次数下降了 52%，而远程评估次数增加了 129%。疫情期间用药不依从的患者比例略有增加，在 axSpA 中差异达到统计学显着性（19.9% vs 疫情前的 13.2%，p=0.003）。疾病发作患者的比例保持稳定（
Objectives To investigate whether the transient reduction in rheumatology services imposed by virus containment measures during the COVID-19 pandemic was associated with disease worsening in axial spondyloarthritis (axSpA), rheumatoid arthritis (RA) or psoriatic arthritis (PsA).Methods Patient-reported disease activity assessed during face-to-face visits and/or via a smartphone application were compared between three periods of each 2 months duration (before, during and after the COVID-19-wave) from January to June 2020 in 666 patients with axSpA, RA and PsA in the Swiss Clinical Quality Management cohort.Results The number of consultations dropped by 52%, whereas the number of remote assessments increased by 129%. The proportion of patients with drug non-compliance slightly increased during the pandemic, the difference reaching statistical significance in axSpA (19.9% vs 13.2% before the pandemic, p=0.003). The proportion of patients with disease flares remained stable (